Skip to content
Search

Latest Stories

Digital exclusion ‘a bottleneck’ to expanding Pharmacy First service

Pharmacies are capable and willing to deliver Pharmacy First Plus services “as long as they are given funding to increase their capacity
An older woman having her ears checked at the clinic by a male doctor (gettyimages)

Baba Akomolafe warns that moving care from hospitals to the community will increase pressure on GPs unless pharmacies are digitally integrated into the NHS primary care system

Pharmacists have the potential to expand Pharmacy First service, but significant barriers such as insufficient funding and digital exclusion of community pharmacies, must be addressed.

“Digitalizing needs to be done first,” said Baba Akomolafe, superintendent pharmacist at Christchurch Pharmacy, who sees the exclusion of community pharmacies from the NHS digital system as “an unnecessary bottleneck” in expanding services like Pharmacy First.


The government's elective care reform plan aims to reduce waiting times by shifting services from hospitals to community settings.

However, Baba has voiced concern that it will place more pressure on GPs unless pharmacies are digitally integrated into the NHS primary care system. 

He suggested that, just as patients can communicate with their GP and book appointments via the NHS app, they should also be allowed to refer themselves to their chosen pharmacy through the app.

GettyImages 1347722233

Speaking to Pharmacy Business, Baba argued: “What is the point of patients referring themselves to the GP digitally, and then the GP referring them to the pharmacies through an analogue system? Why doesn't the digital system give the patient the choice of pharmacies when AI could easily identify that their symptoms can be seen by a pharmacist?

He explained that if pharmacies were included in the NHS app, patients could simply search for available services like 'sore throat' and be directed to the nearest pharmacist.

Baba believes that this change would also improve awareness of available pharmacy services, ultimately benefiting both patients and healthcare providers.

"Pharmacy, as a profession, is very agile and innovative, but you can only be innovative with what’s given. If we are given the funding to innovate, we will do so.”

“When we're digitalized, GPs will feel great relief knowing their inboxes won't be filled with referrals that could have gone straight to the pharmacy. It's a win-win for everybody,” he added.

Expanding the role of pharmacies in ENT Services

When asked if the sector is ready to deliver more ENT services, as proposed in the plan, Baba said that pharmacies can and are willing to do more “as long as they are given funding to increase their capacity.”

He highlighted the success of a pilot ENT project that Christchurch Pharmacy ran between February 2023 and July 2023.

In the pilot, the pharmacy carried out earwax removal and made referrals to ENT specialists when infections were detected as they didn't have Pharmacy First at that time.

The project involved four pharmacies across Essex, including Christchurch Pharmacy, who were compensated directly by the local council for the service.

Baba pointed to the success of this initiative as evidence that pharmacies can deliver expanded Pharmacy First ENT services.

Currently, Christchurch Pharmacy provides earwax removal as a private service, treating around 1,500 patients a year. 

Baba told Pharmacy Business that his pharmacy would be happy to offer this service under the NHS Pharmacy First service at a fee lower than he charges patients privately, as it did during the pilot phase, if the necessary digital infrastructure and funding are put in place.

Need to increase capacity and competence

Beyond digital integration, Baba stated that pharmacists will need to increase both their capacity and competence to take on additional roles.

This includes expanding premises to provide more consultation rooms and upskilling staff to enhance their clinical roles.

Baba also highlighted the importance of the Hub and Spoke model, which would enable pharmacies to outsource dispensing to third parties, allowing staff to focus more on clinical tasks.

However, training pharmacists to become Independent Prescribers (IPs) remains a challenge, as Baba pointed out the difficulty in finding trainers or Designated Prescribing Practitioners (DPPs) willing to mentor them.

This is particularly because experienced prescribers do not get paid to train pharmacists.

Baba said: “My staff who are willing to upgrade or upskill don't find any training opportunities.”

“Pharmacists are expected to beg experienced prescribers to accommodate them. But why would somebody train your pharmacist without getting paid?”

He called for financial incentives for trainers to help pharmacists become IPs to enable them to offer expanded services.

A call for reform

Baba's message to the government is clear: “There's no point reforming the policies without helping us to reform our practice and premises.”

Baba concluded by reiterating the need for government action on digital integration, training incentives, capacity building, and the implementation of the hub and spoke model.

.

More For You

How community pharmacies can safely and profitably deliver high-quality NHS and private services

L-R: Baba Akomolafe, Rachna Chhatralia, Patricia Tigenoah-Ojo, and Raj Matharu

How community pharmacies are optimising services for a sustainable future

“Community pharmacy has come to a point where we have to change ourselves,” said Raj Matharu, CEO at Community Pharmacy South East London, and Superintendent Pharmacist of Westchem Pharmacy, as he opened a panel discussion at the recent Pharmacy Business Conference.

The 'Optimising Service Opportunities' session centred on how community pharmacies can safely and profitably deliver high-quality NHS and private services, while ensuring an excellent patient experience.

Keep ReadingShow less
Branded OTC products can boost pharmacy revenue and promote self-care, says PAGB CEO

Michelle Riddalls

How branded OTC products can help struggling community pharmacies - PAGB chief explains

Branded over-the-counter (OTC) products could play a vital role in promoting self-care and supporting the sustainability of community pharmacies, said Michelle Riddalls, CEO of PAGB – the consumer healthcare association – during the recent Pharmacy Business Conference.

Riddalls emphasised that OTC medicines not only enable consumers to better manage their health through self-care but also offer pharmacies an opportunity to increase revenue, particularly during a time of mounting financial pressure.

Keep ReadingShow less
How Peptides Are Transforming Modern Drug Development

Modern Drug Development

How Peptides Are Transforming Modern Drug Development

The pharmaceutical industry is rapidly evolving, embracing new technologies and methodologies. Peptides are emerging as a crucial component in this transformation, offering innovative solutions to drug development. This shift is not only reshaping how drugs are discovered but also enhancing their efficacy and safety.

In recent years, the pharmaceutical landscape has undergone significant changes, driven by advancements in technology and scientific understanding. One of the most promising areas of innovation is the use of peptides in drug development. These short chains of amino acids have proven to be versatile tools, capable of targeting specific cells or molecules with high precision. In this context, certain bpc 157 peptide research peptides have been highlighted for their potential applications in various therapeutic areas, showcasing the promise that peptides hold for modern pharmaceutical studies.

Keep ReadingShow less
Off-patent medicines could save NHS millions—but only if UK remains attractive to suppliers - BGMA

BGMA chief executive Mark Samuels urges government to back off-patent medicines ahead of Life Sciences Plan release.

UK risks losing millions in NHS savings without stronger support for generics - BGMA

The British Generic Manufacturers Association (BGMA) has called on the government to create a more supportive environment for the generics and biosimilars sector, warning that the UK risks missing out on significant NHS savings arising from new off-patent medicines.

According to the BGMA, 31 medicines are due to lose patent protection between January and June 2025, with a further 28 set to follow in the second half of the year.

Keep ReadingShow less
Janet Morrison discusses pharmacy funding strategy at 2025 conference

Health Secretary Wes Streeting outlines government support for community pharmacy

CPE calls new funding deal a ‘reluctant yes’

Community Pharmacy England (CPE) was “reluctant” to accept the new pharmacy funding deal due to the significant funding gap, said the organisation’s chief executive Janet Morrison, while recognising the settlement as the first step towards stabilising the sector.

Addressing the 2025 Pharmacy Business Conference on Sunday at London Hilton Wembley, Janet shared insights into the behind-the-scenes work that led to the agreement.

Keep ReadingShow less